KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for BioNTech SE (BNTX) over the last 7 years, with Q3 2025 value amounting to 0.14.

  • BioNTech SE's Asset Utilization Ratio rose 515.67% to 0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14, marking a year-over-year increase of 515.67%. This contributed to the annual value of 0.12 for FY2024, which is 2893.03% down from last year.
  • As of Q3 2025, BioNTech SE's Asset Utilization Ratio stood at 0.14, which was up 515.67% from 0.13 recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Asset Utilization Ratio peaked at 105105.54 during Q1 2021, and registered a low of 0.12 during Q1 2024.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.39 (2023), whereas its average is 9785.85.
  • Within the past 5 years, the most significant YoY rise in BioNTech SE's Asset Utilization Ratio was 7259090768.02% (2021), while the steepest drop was 9999.93% (2021).
  • Over the past 5 years, BioNTech SE's Asset Utilization Ratio (Quarter) stood at 1.28 in 2021, then crashed by 38.34% to 0.79 in 2022, then tumbled by 78.7% to 0.17 in 2023, then decreased by 27.26% to 0.12 in 2024, then grew by 16.74% to 0.14 in 2025.
  • Its Asset Utilization Ratio stands at 0.14 for Q3 2025, versus 0.13 for Q2 2025 and 0.13 for Q1 2025.